Target intelligence / Profile preview

Signal sequence receptor subunit 3 (SSR3)

Target
SSR3
Molecular classification
Receptor, Other (Translocon-associated complex subunit, endoplasmic reticulum membrane protein)
01

Overview

SSR3, also known as TRAP-gamma, is a subunit of the signal sequence receptor complex (SSR), which is a component of the translocon-associated protein (TRAP) complex. This endoplasmic reticulum membrane protein plays crucial roles in protein translocation across the ER membrane, integration of nascent polypeptides into the ER, and regulation of signal sequence recognition. It is also involved in transmembrane helix insertion, modulation of ER stress responses, regulation of glycoprotein biosynthesis, and calcium binding. Dysfunction of SSR3 has been implicated in various diseases, including congenital disorders of glycosylation, a severe early-onset progressive encephalopathy syndrome, and certain cancers like hepatocellular carcinoma, suggesting its potential as a therapeutic target.

Other names
Translocon-associated protein subunit gammaTRAP-gammaSignal sequence receptor subunit gammaTRAPGSSR-gammaTRAP-complex gamma subunit
02

Biological functions

Protein translocation across the endoplasmic reticulum membraneIntegration of nascent polypeptides into the ERRegulation of signal sequence recognitionTransmembrane helix insertionModulation of ER stress responsesRegulation of glycoprotein biosynthesisCalcium binding and retention of ER resident proteins
03

Disease associations

Congenital disorder of glycosylationEarly-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndromeCancer (e.g., hepatocellular carcinoma)

Beyond the preview

Go deeper on Signal sequence receptor subunit 3 (SSR3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signal sequence receptor subunit 3 (SSR3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call